European Archives of Psychiatry and Clinical Neuroscience 2/2012

nach oben

Inhaltsverzeichnis ( 12 Artikel )

01.03.2012 | Editorial | Ausgabe 2/2012 Open Access

Neurobiology of schizophrenia: from outcome to pathophysiological insights

P. Falkai, H. -J. Möller

PDF-Version jetzt herunterladen Zum Volltext

01.03.2012 | Original Paper | Ausgabe 2/2012

Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder

Rafael Segarra, Natalia Ojeda, Arantzazu Zabala, Jon García, Ana Catalán, Jose Ignacio Eguíluz, Miguel Gutiérrez

01.03.2012 | Original Paper | Ausgabe 2/2012

General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia

János M. Réthelyi, Pál Czobor, Patrícia Polgár, Beatrix Mersich, Sára Bálint, Éva Jekkel, Krisztina Magyar, Ágnes Mészáros, Ágnes Fábián, István Bitter

01.03.2012 | Original Paper | Ausgabe 2/2012

A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis

Leonhard Lennertz, Michael Wagner, Wolfgang Wölwer, Anna Schuhmacher, Ingo Frommann, Julia Berning, Svenja Schulze-Rauschenbach, Martin W. Landsberg, Anja Steinbrecher, Michael Alexander, Petra E. Franke, Ralf Pukrop, Stephan Ruhrmann, Andreas Bechdolf, Wolfgang Gaebel, Joachim Klosterkötter, Heinz Häfner, Wolfgang Maier, Rainald Mössner

01.03.2012 | Original Paper | Ausgabe 2/2012

Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder

Tessa Christodoulou, Lambros Messinis, Panagiotis Papathanasopoulos, Sophia Frangou

01.03.2012 | Original Paper | Ausgabe 2/2012

Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders

Victor Peralta, Virginia Basterra, Maria S. Campos, Elena García de Jalón, Lucía Moreno-Izco, Manuel J. Cuesta

01.03.2012 | Original Paper | Ausgabe 2/2012

Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

Rosario de Arce Cordón, Evelin Eding, Joao Marques-Teixeira, Vihra Milanova, Elmars Rancans, Andreas Schreiner

01.03.2012 | Original Paper | Ausgabe 2/2012

Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., “intervention in at-risk states for developing psychosis.” (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90–94)

Hsiang-Yuan Lin, Yen-Nan Chiu, Chen-Chung Liu

Aktuelle Ausgaben

European Archives of Psychiatry and Clinical Neuroscience 1/2021

Neu im Fachgebiet Psychiatrie

26.02.2021 | Insomnie | Nachrichten

Springer Medizin

European Archives of Psychiatry and Clinical Neuroscience

Ausgabe 2/2012

Inhaltsverzeichnis ( 12 Artikel )

Neurobiology of schizophrenia: from outcome to pathophysiological insights

Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder

General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia

A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis

Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder

Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders

Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

Critical trial-related criteria in acute schizophrenia studies

Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics

Differential expression of HINT1 in schizophrenia brain tissue

Investigation of schizophrenic patients from Istanbul, Turkey for the presence of West Nile virus

Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., “intervention in at-risk states for developing psychosis.” (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90–94)

Aktuelle Ausgaben

Ausgabe 1/2021

Ausgabe 8/2020

Ausgabe 7/2020

Ausgabe 6/2020

Ausgabe 5/2020

Ausgabe 4/2020

Ausgabe 3/2020

Ausgabe 2/2020

Ausgabe 1/2020

Ausgabe 8/2019

Neu im Fachgebiet Psychiatrie

Inseln der Wachheit im Schlaf

Schlaf und psychische Gesundheit – ein sensibles Wechselspiel

Isolierte TSH-Erhöhung: Levothyroxin schützt nicht vor Depression

Antipsychotika: Was bringt ein Cytochrom-Screening zur Therapiesteuerung?